Timeline

Abstract submission deadline: 31st August, 2024 (23:59 hrs GMT )

Notification of acceptance: 15th August, 2024

Guidelines

Please read these guidelines carefully. A printout could assist you while using the system.

It is not permitted to submit work that has been published and/or is likely to be published before the DFSICON 2024. The Programme Committee has the right to remove an abstract if this contains data that has already been published. Authors submitting prior published or presented work or any form of plagiarism (shall be checked by Ithenticate software) will be banned from presenting data at the DFSICON Meetings for three years.

The DFSICON2024 online abstract submission is only available via the DFSICON2024 Abstract Submission Platform; you will need to create a DFSICON2024 account via the DFSICON2024 website to have access. Please make sure to always enter the first name starting with a capital letter and continue with lower case, e.g. First Name: John; 2nd Initial: J; 3rd Initial: R; Last Name: Macleod, address, contact details, etc. Do not type in everything in capital letters.

Once logged in Online DFSICON Abstract System, please proceed to Abstract Submission where you will be able to start your New Abstract Submission.

Important Note: All correspondence regarding the handling of each abstract will be sent ONLY to the presenting = first named author's contact e-mail provided during the submission process (only one e-mail address per presenting = first named author). Therefore, the e-mail address entered in the system as the presenting author's contact is extremely important!

Disclosure Information

• All authors are aware of and approve the submission of this paper.
• Each author has participated sufficiently in the work represented by the abstract submission to take public responsibility for the content.
• Corresponding author shall hold the responsibility including ethical approval, consent and plagiarism check for the Work being submitted for DFSICON 2024
• Presenting authors may be co-authors of other abstracts. It is mandatory that the presenting author of any abstract accepted for presentation attends the 21st DFSICON 2024 to present his / her paper. Failure to do so, without prior or adequate explanation sent to the DFSICON2024 Office by e-mail, may result in the author or the institution being banned from presenting abstracts for the next three years.
• All co-authors must be entered individually. The maximum number of authors is 10 and not more than 1 institutions can be entered for each author.
• The abstract must be structured. Enter each section into the corresponding text field with the provided sub-headings in bold (Background and aims:, Materials and methods:, Results: and Conclusion:). The abstract structuring words are fixed for each abstract text box. One or two sentences should describe the methods, and any aspects of methodology (e.g. use of control groups, randomisation, patient selection, assay variation). The sentences stating the results must include hard data, including statistical analysis.
• For drugs exclusively generic names should be used (no trademarks).
• You are allowed to include only one table OR one graph to your abstract by using the button provided (under the abstract text in the Abstract submission step), but 400 characters will be deducted from the maximum number of characters allowed. Tables must be uploaded as an image; so you must create your table and convert it into an image in order to include it in your abstract.
• Please write your acknowledgement on a grant / support received for the study into the provided field. Please enter "none" if not applicable. The limit for acknowledgements is 15 words.
• Note: Acknowledgements will be displayed at the bottom of the abstract if accepted for presentation.
• References are not allowed and companies are not to be mentioned in the abstract body. If you still enter any of these in the abstract, you will be contacted and reminded to remove them from the abstract text.
• Read your abstract carefully, check the authors and if all special characters are shown correctly. Only if all submission steps are ticked and the number of characters does not exceed 3,200 the abstract is "complete" (please check the status given at the bottom of the print-friendly version) and will thus be forwarded to the reviewers after the submission deadline.
• PLEASE NOTE: Each author can be listed ONLY ONCE as the PRESENTING author (presenting author is always the first named author in the author block) for ONE (1) abstract. Each additional abstract will be removed from the system before being sent to the Review Committee.
• The system will lead you through all steps necessary to complete your abstract. For any step, please refer to / follow the advice provided on the screen. By clicking the Save And Proceed button, all entered information is saved.

Abstract Categories:

A) Medical Sciences Abstract

B) Surgical Sciences Abstract